Market closed

Baxter/$BAX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Baxter

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.

Ticker

$BAX

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Employees

60,000

Baxter Metrics

BasicAdvanced
$17B
Market cap
159.21
P/E ratio
$0.21
EPS
0.60
Beta
$1.16
Dividend rate
3.43%
Dividend yield
$17B
0.6
$44.01
$32.48
3.6M
$1.16
173.106
3.73%
159.205
1.142
2.26
-4.21
3.43%
3.43%
-1.43%
-95.85%
6.55%
-55.28%
3.38%

What the Analysts think about Baxter

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Baxter stock.

Baxter Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Baxter Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BAX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Nov
29
Baxter
Dividend·Ex-dividend
Jan
2
Baxter
Dividend·Payment
$0.17
Per share

FAQs

What’s the current market cap for Baxter stock?

Baxter (BAX) has a market cap of $17B as of November 14, 2024.

What is the P/E ratio for Baxter stock?

The price to earnings (P/E) ratio for Baxter (BAX) stock is 159.21 as of November 14, 2024.

Does Baxter stock pay dividends?

Yes, the Baxter (BAX) stock pays dividends to shareholders. As of November 14, 2024, the dividend rate is $1.16 and the yield is 3.43%. Baxter has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Baxter dividend payment date?

The next Baxter (BAX) dividend payment is scheduled for January 02, 2025.

What is the beta indicator for Baxter?

Baxter (BAX) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.